Lysyl hydroxylase 2 is secreted by lung cancer cells in culture, and its hydroxylation of collagen telopeptidyl lysine residues leads to the formation of stable hydroxylysine aldehyde-derived collagen cross-links that are up-regulated in lung cancer tissue and generate stiffer tumour tissue (39, 40). The gene discussed is PLOD2; the disease is lung cancer.